ClinicalTrials.gg
RecruitingNCT06815731Updated Feb 7, 2025

Multicenter Study on the Correction of Prolapse Via Laparoscopy

An interventional study of lateral laparoscopic suspension (LLS) and Sacropexy without posterior mesh fixation on the puborrectalis muscle in Pelvic Floor Disorders, sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-07.

Sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 3 months after the study started (first participant enrolled Oct 2023, registered Jan 2025).
  • Started Oct 2023; still recruiting 3 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
181
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 29 studies in Pelvic Floor Disorders with a site in Spain — 9 open to participants now, 10 under way, none of them phase 3. Pelvic Floor Disorders · Spain.

Planned enrollment
3rd of 26
181 · median 68
Started
2023
with 4 others
No phase
25 of 29
7 open now
Registered
25th of 29
by date
Lead sponsor
1 of 29
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Among the 29 studies in Pelvic Floor Disorders with a site in Spain, this one is the 3rd largest by planned enrollment of the 26 interventional ones, is one of 5 that started in 2023, is one of 25 with no phase, and was the 25th registered.

By phase

29 studies; the count open now beside each. This study's row is marked.

No phasethis study25 · 7 open
Observational3 · 2 open
Phase 31 · 0 open

By the year they started

First in 2013; this study’s year is marked. 5 started in 2023.

Size and results

Median enrollment 68 across the 26 interventional studies, 105 across the 3 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 29 studies in Pelvic Floor Disorders with a site in Spain, or all of them as a file.
02

Study summary

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

Read the detailed description

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

03

Conditions studied

  • Pelvic Floor Disorders
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with Stage II- IV primary or recurrent prolapse affecting the anterior or middle vaginal compartment with or without minimal posterior defect (Stage I) according to the POP-Q.

Exclusion criteria

Exclusion Criteria:

  • History of abdominal prolapse reconstructive surgery.
  • History of prolapse reconstructive surgery with vaginal meshes.
  • Stage I according to the POP-Q classification or asymptomatic prolapse.
  • Medical for general anaesthesia.
  • Patient preference for vaginal surgical treatment.
  • Patient does not wish to participate in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
181 participants (estimated)

Study arms

  • Experimental
    lateral laparoscopic suspension (LLS)

    Procedure: lateral laparoscopic suspension (LLS)

  • Active comparator
    Sacropexy without posterior mesh fixation on the puborrectalis muscle

    Procedure: Sacropexy without posterior mesh fixation on the puborrectalis muscle

Interventions

  • Procedurelateral laparoscopic suspension (LLS)

    lateral laparoscopic suspension (LLS)

  • ProcedureSacropexy without posterior mesh fixation on the puborrectalis muscle

    Sacropexy without posterior mesh fixation on the puborrectalis muscle

06

What researchers measure

Primary outcomes

  1. Pelvic Organ Prolapse Distress Inventory

    Pelvic Organ Prolapse Distress Inventory (POPDI-6) Scores range between 0 and 24 for the POPDI-6

    Time frame: up to 12 months

  2. Colorectal-Anal Distress Inventory

    Colorectal-Anal Distress Inventory (CRADI-8) Scores between 0 and 32 for the CRADI-8

    Time frame: up to 12 months

  3. Urinary Distress Inventory

    Urinary Distress Inventory (UDI-6) Scores between 0 and 24 for the UDI-6.

    Time frame: up to 12 months

  4. Number of patients with symptomatic failure

    Number of patients with symptomatic failure , defined as a positive response (accompanied by any degree of discomfort) to the following question on the validated questionnaire regarding prolapse symptoms (PFDI-20): "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?"

    Time frame: up to 12 months

Secondary outcomes

  1. Intestinal and pain symptoms

    Subjective or functional success is defined as an improvement of ≥15 points per domain (the minimally important difference) or a decrease in the total score of 45 points (the minimally important difference). The PISQ-2 questionnaire has a score range between 0 and 48, and a difference ≥ 6 points is considered a minimally important difference.

    Time frame: up to 12 months

  2. Anatomical result

    Anatomical results are defined as any POP-Q measurement below the hymen. Anatomical variables of prolapse: POPQ classification : * Anterior compartment: Aa, Ba * Middle compartment: C or D * Posterior compartment: Ap, Bp

    Time frame: up to 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Apr 2025, 18 months after the start.

Of 101 non-industry interventional studies with no phase under Pelvic Floor Disorders, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 18 months is above that.

Counting every sponsor, half of 107 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2025
First posted
Feb 7, 2025
StartActual
Oct 1, 2023
Primary completionEst.
Apr 30, 2025
CompletionEst.
May 30, 2026
Last update
Feb 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06815731
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Responsible party
Sponsor
First posted
Feb 7, 2025
Start date
Oct 1, 2023
Primary completion
Apr 30, 2025 (estimated)
Completion
May 30, 2026 (estimated)
Last update
Feb 7, 2025

Study contacts

María Luisa Sánchez Ferrer, MD
Contact
marisasanchezferrer1@gmail.com
968369500

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion